-
β-Pseudouridine for RNA Fidelity Workflows
2026-08-17
β-Pseudouridine supports practical RNA modification studies spanning analytical calibration, exogenous nucleoside perturbation, and translational-fidelity assays. This workflow guide also clarifies a critical distinction: the free C-glycoside isomer of uridine is a research reagent and reference standard, not a direct substitute for an activated nucleotide used during in vitro RNA synthesis.
-
Tubastatin A: From HDAC6 Selectivity to Translation
2026-08-17
Tubastatin A is more than a selective HDAC6 inhibitor: it is a mechanistic probe linking protein acetylation, cytoskeletal behavior, inflammatory signaling, and regulated cell death. New porcine cardiac-arrest data sharpen its translational potential while defining the evidence boundaries researchers must respect.
-
Primidone: From Target Biology to ALS Assays
2026-08-16
Primidone (Mysoline) is more than an established antiepileptic drug: its concentration-dependent effects on TRPM3, RIPK1, and hPON1 create distinct research opportunities. This guide converts mechanistic and clinical evidence into practical assay, dosing, and translational decisions.
-
Sulfisomidine: Bench Workflows for Microbes and hPON1
2026-08-15
Sulfisomidine, also known as sulfamethin, connects bacterial folate-pathway research with human serum paraoxonase 1 inhibition studies. This practical guide covers solution preparation, enzyme kinetics, microbial assays, environmental workflows, and troubleshooting for reproducible bench applications.
-
Puromycin Aminonucleoside: Reliable Injury Models
2026-08-14
This scenario-driven guide explains how Puromycin aminonucleoside, SKU A3740, can support controlled podocyte injury, cytotoxicity, and nephrotic disease-modeling workflows. It covers concentration selection, pH-dependent uptake, solubility, storage, data interpretation, and practical vendor evaluation.
-
PNU 74654: Wnt Signaling Workflow Guide
2026-08-14
PNU 74654 provides a DMSO-compatible perturbation tool for testing Wnt/β-catenin control of transcription, cell fate, and proliferation. This workflow separates literature-validated muscle progenitor biology from exploratory applications in cancer research and stem cell research, with practical controls for solubility, dosing, and pathway-specific readouts.
-
Nile Red Workflow for Lipid Droplet Imaging
2026-08-13
Build a dual-channel Nile Red assay that distinguishes lipid droplets from membrane-associated fluorescence while supporting quantitative lipid storage analysis. The workflow translates findings from an oleic acid lipid-accumulation study into practical imaging, control, and troubleshooting decisions.
-
Schizophrenia Risk Loci in Developing Neurons
2026-08-13
Liu et al. show that schizophrenia-associated GWAS loci converge on different molecular pathways in developing cortical interneurons and glutamatergic neurons. Their combination of iPSC-derived neuronal models, regulatory genomics, morphology, and electrophysiology provides a cell-type-specific framework for interpreting schizophrenia risk mechanisms during neurodevelopment.
-
IWP-L6 for Reliable Wnt Pathway Assays
2026-08-12
Learn how IWP-L6, SKU B2305, can help researchers distinguish Wnt pathway effects from nonspecific cytotoxicity in viability, proliferation, developmental, and metabolic assays. This scenario-based guide covers concentration selection, DMSO handling, interpretation, and vendor reliability using product data and recent Wnt literature.
-
Patient-Derived Spheroids in Organ-Confined Prostate Cancer
2026-08-12
Linxweiler and colleagues developed viable three-dimensional spheroid cultures from radical prostatectomy specimens and characterized them as a translational model of organ-confined prostate cancer. The cultures retained key epithelial and prostate cancer markers, could be cryopreserved, and showed differential responses to androgen receptor-directed and cytotoxic drugs, highlighting their value for patient-derived prostate cancer research.
-
Measuring Drug Response Beyond Cell Viability
2026-08-11
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent dimensions of anticancer drug response. This framework helps researchers interpret assay timing, separate cytostatic effects from cytotoxicity, and design more informative in vitro studies.
-
Chicken GSDME Drives RNA Virus Pyroptosis
2026-08-11
The reference study identifies chicken GSDME as a major pore-forming effector of RNA virus-induced pyroptosis, addressing the unresolved role of avian gasdermins in the absence of GSDMD. Its genetic and pathway-level evidence connects MDA5 signaling with caspase-3/7-mediated GSDME cleavage and shows that GSDME loss reduces both pyroptosis and viral release.
-
Naftifine HCl: From Sterol Biology to Translation
2026-08-10
A mechanistic and translational framework for using Naftifine HCl to interrogate fungal sterol biology, improve assay design, and connect target-level evidence with clinically relevant antifungal research.
-
Lactate–GPR81 Control of Insulin-Independent Glucose Uptake
2026-08-09
The reference study identifies L-lactate as a metabolite that promotes glucose uptake independently of canonical insulin–AKT signaling through a GPR81–FARP1–RAC1–GLUT4 pathway. Its combination of muscle genetics, pharmacological perturbation, exercise biology, and human genetic association provides a mechanistic framework for understanding lactate as an active regulator of glucose homeostasis rather than only a metabolic by-product.
-
Deep Learning of Urine Stem Cell Mitochondria in AD
2026-08-08
Yan et al. developed a deep learning workflow that classifies mitochondrial morphology in live urine-derived stem cells, linking peripheral cellular phenotypes with Alzheimer’s disease and mild cognitive impairment. The study supports urine-derived cells as an accessible research platform for mitochondrial biomarker development, while emphasizing the need for larger, independent validation cohorts.